The marine polyketide myriaporone 3/4 stalls translation by targeting the elongation phase

Chembiochem. 2013 Jan 21;14(2):260-4. doi: 10.1002/cbic.201200522. Epub 2013 Jan 9.

Abstract

Myriaporone 3/4, a cytotoxic polyketide, has been reported as an inhibitor of eukaryotic protein synthesis. However, the mechanism by which it inhibits translation was unknown. Here we show that myriaporone 3/4 stalls protein synthesis in the elongation phase by inducing phosphorylation of eukaryotic elongation factor 2. The phosphorylation results from direct binding of myriaporone 3/4 to eukaryotic elongation factor 2 kinase. Our study also shows that myriaporone 3/4 in the nanomolar range inhibits in vitro tube formation by endothelial cells without being cytotoxic. In general, myriaporone 3/4 was at least 300 times less toxic to primary cells than to tumor cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Bryozoa / chemistry
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Elongation Factor 2 Kinase / metabolism
  • Epoxy Compounds / pharmacology*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Peptide Elongation Factor 2 / metabolism*
  • Phosphorylation / drug effects
  • Protein Biosynthesis / drug effects*
  • Pyrans / pharmacology*

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Epoxy Compounds
  • Peptide Elongation Factor 2
  • Pyrans
  • myriaporone 3
  • Elongation Factor 2 Kinase